Stock listing
NASDAQ:PCYC Pharmacyclics Inc Stock
Follow Pharmacyclics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:PCYC
$261.25 USD
Close on May 22, 2015 · No longer trades
- Lowest – highest close
- $0.57 – $261.25 USDSince Jan 4, 1999 · lowest Feb 20, 2009 · highest May 22, 2015
Delisted NASDAQ:PCYC no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:PCYC
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Pharmacyclics Inc on 6ix
- Decks
- 37 decks · latest Mar 5, 2015
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (March 2015) | Merger or acquisition | 20 slides | Mar 5, 2015 |
| 33rd Annual J.P. Morgan Healthcare Conference (January 2015) | Conference | 38 slides | Jan 13, 2015 |
| Technical Presentation (June 2014) | Technical | 18 slides | Jun 5, 2014 |
| American Society of Hematology Annual Meeting 2013 | Conference | 17 slides | Dec 11, 2013 |
| Technical Presentation (December 2013) | Technical | 18 slides | Dec 11, 2013 |
| Technical Presentation (December 2013) | Technical | 22 slides | Dec 11, 2013 |
| Technical Presentation (December 2013) | Technical | 20 slides | Dec 11, 2013 |
| Technical Presentation (September 2013) | Technical | 26 slides | Sep 10, 2013 |
| Technical Presentation (June 2013) | Technical | 16 slides | Jun 21, 2013 |
| Technical Presentation (June 2013) | Technical | 26 slides | Jun 20, 2013 |
All 37 decks
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Manmeet Soni Other companies: Summit Therapeutics Inc. (Chief Operating Officer, Chief Financial Officer & Director · Since at least Sep 18, 2020); Pulse Biosciences, Inc (Director · Since at least Nov 2, 2017); Reata Pharmaceuticals Inc (COO, CFO and President · Aug 28, 2019 – Sep 26, 2023 · Past); Arena Pharmaceuticals Inc (Director · Dec 14, 2018 – Jun 17, 2020 · Past); Alnylam Pharmaceuticals, Inc. (Chief Financial Officer · May 9, 2017 – Feb 28, 2019 · Past); Ariad Pharmaceuticals Inc (EVP, CFO & Treasurer · Mar 21, 2016 – Feb 16, 2017 · Past) | Chief Financial Officer · Feb 13, 2013 – May 26, 2015 · Past |
| Richard A. van den Broek Other companies: Corvus Pharmaceuticals, Inc. (Board Member · Since at least Apr 8, 2025); Pulse Biosciences, Inc (Director · Since at least Aug 6, 2020); PhaseBio Pharmaceuticals Inc (Director · Feb 27, 2019 – May 19, 2023 · Past); Celldex Therapeutics, Inc. (Director · Dec 17, 2014 – Jun 8, 2016 · Past) | Director · Oct 3, 2011 – May 26, 2015 · Past |
| Fong Clow Other companies: Summit Therapeutics Inc. (Chief Biometrics Officer · Since at least Nov 5, 2026); Paratek Pharmaceuticals Inc (Senior V.P., Development · May 9, 2006 – Jan 17, 2007 · Past) | VP Biostatistics Data Mgmt · Sep 24, 2012 – Apr 30, 2013 · Past |
| Kenneth A. Clark Other companies: Summit Therapeutics Inc. (Lead Independent Director · Since at least Oct 7, 2021); Pulse Biosciences, Inc (Director · Nov 2, 2017 – May 20, 2021 · Past) | Director · Nov 9, 2012 – May 26, 2015 · Past |
| Thorsten Graef Other companies: Artiva Biotherapeutics, Inc. (Chief Medical Officer · Jul 18, 2024 – Feb 26, 2025 · Past) | VP, Clinical Science · Jul 9, 2013 – Oct 31, 2013 · Past |
| Christopher Suchet | VP Information Technology · Mar 18, 2013 – Oct 31, 2013 · Past |
| Cynthia Bamdad | Director · Oct 9, 2008 – Oct 1, 2010 · Past |
| David Duane Smith | Director · Apr 1, 2013 – May 26, 2015 · Past |
| Heow Tan | Chief Quality&Tech Operations · Jul 20, 2012 – May 26, 2015 · Past |
| James N MD Lowder | VP Clinical Development · Jul 24, 2008 – Jul 24, 2008 · Past |
All 11 people
| Person | Seat |
|---|---|
| Matthew Outten | VP, Commercial Operations · Mar 10, 2014 – Apr 30, 2014 · Past |
Log in to ask 6ix AI your own questions about Pharmacyclics Inc.